AU2002257004A1 - Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators - Google Patents
Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulatorsInfo
- Publication number
- AU2002257004A1 AU2002257004A1 AU2002257004A AU2002257004A AU2002257004A1 AU 2002257004 A1 AU2002257004 A1 AU 2002257004A1 AU 2002257004 A AU2002257004 A AU 2002257004A AU 2002257004 A AU2002257004 A AU 2002257004A AU 2002257004 A1 AU2002257004 A1 AU 2002257004A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- angiogenesis
- diagnosis
- screening
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78435601A | 2001-02-14 | 2001-02-14 | |
| US09/784,356 | 2001-02-14 | ||
| US79139001A | 2001-02-22 | 2001-02-22 | |
| US09/791,390 | 2001-02-22 | ||
| US28547501P | 2001-04-19 | 2001-04-19 | |
| US60/285,475 | 2001-04-19 | ||
| US31002501P | 2001-08-03 | 2001-08-03 | |
| US60/310,025 | 2001-08-03 | ||
| US35066601P | 2001-11-13 | 2001-11-13 | |
| US60/350,666 | 2001-11-13 | ||
| US33424401P | 2001-11-29 | 2001-11-29 | |
| US60/334,244 | 2001-11-29 | ||
| PCT/US2002/004915 WO2002079492A2 (en) | 2001-02-14 | 2002-02-14 | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002257004A1 true AU2002257004A1 (en) | 2002-10-15 |
Family
ID=27559580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002257004A Abandoned AU2002257004A1 (en) | 2001-02-14 | 2002-02-14 | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1418943A1 (en) |
| JP (1) | JP2004531249A (en) |
| AU (1) | AU2002257004A1 (en) |
| CA (1) | CA2438030A1 (en) |
| WO (1) | WO2002079492A2 (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| EP1385861A2 (en) | 2000-10-25 | 2004-02-04 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| AU2003234274A1 (en) | 2002-04-26 | 2003-11-10 | California Institute Of Technology | D1-1 nucleic acids, polypeptides and related methods |
| US7622443B2 (en) | 2002-04-26 | 2009-11-24 | California Institute Of Technology | Method for inhibiting pro-angiogenic activities of endothelial cells selectively at a site of neoangiogenesis in a mammal by administration of the extracellular domain of D1-1 polypeptides |
| ES2359055T3 (en) * | 2002-09-11 | 2011-05-18 | Genentech, Inc. | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TUMOR TREATMENT. |
| US7276589B2 (en) | 2002-11-26 | 2007-10-02 | Pdl Biopharma, Inc. | Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| US7285268B2 (en) | 2002-11-26 | 2007-10-23 | Pdl Biopharma, Inc. | Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| EP1608255A4 (en) * | 2003-04-01 | 2008-06-25 | Univ Johns Hopkins Med | Breast endothelial cell expression patterns |
| EP1619499B1 (en) | 2003-04-25 | 2011-01-05 | Takeda Pharmaceutical Company Limited | Novel screening method |
| US7267950B2 (en) * | 2003-05-01 | 2007-09-11 | Veridex, Lcc | Rapid extraction of RNA from cells and tissues |
| US9309323B2 (en) | 2003-06-09 | 2016-04-12 | The University Of British Columbia | Methods for detecting and treating cancer |
| US7833733B2 (en) | 2003-06-09 | 2010-11-16 | The University Of British Columbia | Methods for detecting and treating cancer |
| US20070105169A1 (en) * | 2003-06-30 | 2007-05-10 | Lydie Bougueleret | Secreted polypeptide species associated with cardiovascular disorders |
| US7485297B2 (en) | 2003-08-12 | 2009-02-03 | Dyax Corp. | Method of inhibition of vascular development using an antibody |
| DE10340373A1 (en) * | 2003-08-30 | 2005-03-24 | Henkel Kgaa | Determining the hair cycle in humans, by measuring protein or mRNA levels and classification as anagenic or catagenic, also for screening therapeutic or cosmetic agents that affect hair growth |
| JP2005073621A (en) * | 2003-09-01 | 2005-03-24 | Japan Science & Technology Agency | Marker for cerebral tumor and method for diagnosing cerebral tumor |
| US7527936B2 (en) | 2004-01-13 | 2009-05-05 | Rigel Pharmaceuticals Inc. | Modulators of angiogenesis |
| ATE531388T1 (en) | 2004-03-24 | 2011-11-15 | Abbott Biotherapeutics Corp | USE OF ANTI-ALPHA5BETA1 ANTIBODIES TO INHIBIT CANCER CELL PROLIFERATION |
| US7781175B2 (en) | 2004-04-23 | 2010-08-24 | Takeda Pharmaceutical Company Limited | Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid |
| WO2005113788A2 (en) * | 2004-05-21 | 2005-12-01 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 6 (grk6) |
| US8067189B2 (en) * | 2005-09-01 | 2011-11-29 | Bristol-Myers Squibb Company | Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV |
| EP1996619A4 (en) * | 2006-02-14 | 2009-11-18 | Geisinger Clinic | Gpcrs as angiogenesis targets |
| WO2007096142A2 (en) * | 2006-02-22 | 2007-08-30 | Philogen Spa | Vascular tumor markers |
| TWI397535B (en) | 2006-03-21 | 2013-06-01 | Genentech Inc | Combinatorial therapy involving alpha5beta1 antagonists |
| CA2648385C (en) | 2006-04-04 | 2020-09-01 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
| EP2537529B1 (en) | 2007-08-02 | 2018-10-17 | Gilead Biologics, Inc. | Loxl2 inhibitory antibodies and uses thereof |
| TWI547503B (en) | 2007-09-26 | 2016-09-01 | 建南德克公司 | Anti-α5β1 antibodies, nucleic acids encoding and compositions comprising the same, and methods of production and use thereof |
| US9107935B2 (en) | 2009-01-06 | 2015-08-18 | Gilead Biologics, Inc. | Chemotherapeutic methods and compositions |
| EP2216399A1 (en) | 2009-01-30 | 2010-08-11 | Université de la Méditerranée | Human soluble CD146, preparation and uses thereof |
| SG10201609416XA (en) | 2009-03-25 | 2016-12-29 | Genentech Inc | NOVEL ANTI-α5ß1 ANTIBODIES AND USES THEREOF |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| CA2767442A1 (en) | 2009-07-08 | 2011-01-13 | Actgen Inc. | Antibody having anti-cancer activity |
| AU2010284036B2 (en) | 2009-08-21 | 2014-12-18 | Gilead Biologics, Inc. | Catalytic domains from lysyl oxidase and LOXL2 |
| ES2567030T3 (en) | 2009-09-03 | 2016-04-19 | Cancer Research Technology Limited | CLEC14A inhibitors |
-
2002
- 2002-02-14 EP EP02726581A patent/EP1418943A1/en not_active Ceased
- 2002-02-14 WO PCT/US2002/004915 patent/WO2002079492A2/en not_active Application Discontinuation
- 2002-02-14 CA CA002438030A patent/CA2438030A1/en not_active Abandoned
- 2002-02-14 AU AU2002257004A patent/AU2002257004A1/en not_active Abandoned
- 2002-02-14 JP JP2002578493A patent/JP2004531249A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1418943A1 (en) | 2004-05-19 |
| WO2002079492A2 (en) | 2002-10-10 |
| JP2004531249A (en) | 2004-10-14 |
| CA2438030A1 (en) | 2002-10-10 |
| WO2002079492A8 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002257004A1 (en) | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
| AU2002309583A1 (en) | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer | |
| AU2002347428A1 (en) | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer | |
| AU2002245317A1 (en) | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer | |
| AU2002330039A1 (en) | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer | |
| AU6902200A (en) | Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
| AU2002215345A1 (en) | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer | |
| AU2002252144A1 (en) | Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer | |
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| WO2003022987A9 (en) | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection | |
| AU2002249871A1 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
| AU2001290902A1 (en) | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators | |
| AU3755300A (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| AU2002306918A1 (en) | Methods of modulating angiogenesis | |
| AU2002242996A1 (en) | Spiroisoquinoline compounds, methods for their preparation and intermediates | |
| AU2002249467A1 (en) | Screening method | |
| AU2002357734A1 (en) | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer | |
| AU2002367145A1 (en) | Remedies for anorexia or lifestyle-related diseases and method of screening the same | |
| AU2002332696A1 (en) | Solid support dirhodium catalyst compositions and methods for making and using same | |
| AU2002342944A1 (en) | Fiberboards and processes for the preparation thereof | |
| AU2002331753A1 (en) | Dirhodium catalyst compositions and methods for using same | |
| AU2002353772A1 (en) | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection | |
| AU2002348191A1 (en) | Method and composition for the modulation of angiogenesis | |
| AU2002354206A1 (en) | Method of screening drug | |
| AU2002347578A1 (en) | Process for the preparation of dronedarone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |